Innoviva IncINVA
Price$20.55Intrinsic value$20.912% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $20.91median of 4 methods · middle span $20-$22based on filings through 30 Jun 2026
Market Price $20.55Price as of 1 Oct 2026
Margin of Safety +1.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -2.2% (near-term consensus, capped) · years 2–5: -17.9%/yr (balance of the path).-15.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-13.7%Yr 7-9.6%Yr 8-5.4%Yr 9-1.2%Yr 103.0%
-17.9% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)10.3%
Discount rate (cost of equity) 7.5%
Volatility vs market (adjusted beta)0.56

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetInnoviva IncINVAHealth Care
Valuation
P/E4.8×
P/S3.5×
P/B1.5×
EV / Revenue2.8×
EV / EBITDA—
Profitability
Gross margin72.2%
Operating margin39.8%
Net margin81.2%
FCF margin43.1%
Returns
ROE29.0%
ROA21.0%
ROIC38.8%
Growth
Revenue growth (YoY)22.7%
5-yr fwd EPS growth-15.8%
Financial strength
Debt / Equity0.21×
Current ratio16.01×
Altman Z-Score3.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.